Dual blockade of Tim-3 plus PD-1 also has shown positive results in that they enable inhibition of hepatocellular carcinoma cell growth into senescence, suggesting that their modulation may be a rational target for new immunotherapeutic approaches [125]. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.